GGrantIndex
← Search

W81XWH-21-1-0296/NOVEL BIOMARKERS TO DIRECT STEREOTACTIC ABLATIVE RADIOTHERAPY IN CASTRATION-SENSITIVE OLIGOMETASTATIC PROSTATE CANCER.

$1,397,747FY2021Defense Health AgencyDOD

University Of Maryland Baltimore County, Baltimore MD

Investigators

View source on USAspending →
W81XWH-21-1-0296/NOVEL BIOMARKERS TO DIRECT STEREOTACTIC ABLATIVE RADIOTHERAPY IN CASTRATION-SENSITIVE OLIGOMETASTATIC PROSTATE CANCER. · GrantIndex